Viewing Study NCT02428192


Ignite Creation Date: 2025-12-24 @ 3:36 PM
Ignite Modification Date: 2026-01-05 @ 5:59 PM
Study NCT ID: NCT02428192
Status: COMPLETED
Last Update Posted: 2025-02-25
First Post: 2015-04-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-05-19
Start Date Type: ACTUAL
Primary Completion Date: 2018-09-20
Primary Completion Date Type: ACTUAL
Completion Date: 2021-01-28
Completion Date Type: ACTUAL
First Submit Date: 2015-04-23
First Submit QC Date: None
Study First Post Date: 2015-04-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2019-10-18
Results First Submit QC Date: None
Results First Post Date: 2020-05-12
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-02-06
Last Update Post Date: 2025-02-25
Last Update Post Date Type: ACTUAL